Skip to main content
logo
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.9523
+0.0024 (0.25%)
May 15, 2026, 4:00 PM EDT - Market closed

ZYBT Revenue

In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M CNY, down -37.56%. Zhengye Biotechnology Holding had revenue of 54.03M in the half year ending December 31, 2025, a decrease of -43.00%.

Revenue (ttm)
116.36M CNY
Revenue Growth
-37.56%
P/S Ratio
2.71
Revenue / Employee
420,079 CNY
Employees
277
Market Cap
45.13M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025116.36M-69.99M-37.56%
Dec 31, 2024186.36M-25.30M-11.95%
Dec 31, 2023211.65M-48.62M-18.68%
Dec 31, 2022260.27M46.20M21.58%
Dec 31, 2021214.07M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InterCure84.76M
Rockwell Medical67.68M
Aytu BioPharma56.60M
Cumberland Pharmaceuticals41.94M
BGM Group25.10M
SCYNEXIS20.34M
China Pharma Holdings4.14M
BioXcel Therapeutics680.00K
Revenue Rankings

ZYBT News

More News